Gennex Laboratories Ltd

Gennex Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Gennex Laboratories Ltd

₹ 13.9 -2.25%
22 Jul 4:01 p.m.
gennexlab.com BSE: 531739
About

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Key Points

Business Overview:[1][2]
GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants,
Muscle Relaxants, Analgesic and Anti Fungal, etc.

Website BSE
  • Market Cap ₹ 316 Cr.
  • Current Price ₹ 13.9
  • High / Low ₹ 21.9 / 6.15
  • Stock P/E 26.8
  • Book Value ₹ 7.51
  • Dividend Yield 0.00 %
  • ROCE 12.6 %
  • ROE 9.45 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 39.7% CAGR over last 5 years

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -5.18%
  • The company has delivered a poor sales growth of 3.68% over past five years.
  • Promoter holding is low: 18.4%
  • Company has a low return on equity of 8.86% over last 3 years.
  • Earnings include an other income of Rs.4.30 Cr.
  • Working capital days have increased from 286 days to 470 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
16.21 10.40 14.29 16.69 20.18 13.94 19.62 13.90 18.15 14.14 14.24 17.08 21.33
13.65 8.75 12.34 15.36 19.40 13.06 17.77 12.81 16.88 10.22 10.27 15.64 18.24
Operating Profit 2.56 1.65 1.95 1.33 0.78 0.88 1.85 1.09 1.27 3.92 3.97 1.44 3.09
OPM % 15.79% 15.87% 13.65% 7.97% 3.87% 6.31% 9.43% 7.84% 7.00% 27.72% 27.88% 8.43% 14.49%
0.02 0.00 0.00 0.00 1.04 0.57 0.00 0.73 1.59 0.03 0.06 2.24 1.97
Interest 0.21 0.15 0.24 0.14 0.34 0.18 0.36 0.18 0.51 0.30 0.28 0.32 0.25
Depreciation 0.22 0.20 0.20 0.19 0.20 0.26 0.10 0.19 0.20 0.20 0.20 0.20 0.20
Profit before tax 2.15 1.30 1.51 1.00 1.28 1.01 1.39 1.45 2.15 3.45 3.55 3.16 4.61
Tax % 8.84% 26.92% 26.49% 21.00% 16.41% 24.75% 25.18% 24.83% 22.33% 25.22% 25.07% 16.46% 14.75%
1.95 0.95 1.11 0.79 1.07 0.75 1.05 1.08 1.67 2.57 2.66 2.64 3.93
EPS in Rs 0.10 0.05 0.06 0.04 0.06 0.04 0.06 0.07 0.09 0.15 0.15 0.15 0.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
30 35 32 39 42 44 56 56 60 61 65 67
28 33 30 34 37 42 52 52 53 56 61 54
Operating Profit 2 2 2 4 5 2 4 3 7 5 5 12
OPM % 5% 5% 6% 11% 11% 5% 7% 6% 11% 9% 7% 19%
0 0 0 0 0 1 1 1 0 1 3 4
Interest 0 0 0 0 1 1 1 1 1 1 1 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 0 1 1 3 3 1 3 3 5 5 6 15
Tax % 17% 70% 23% 23% 13% 42% 26% 27% 20% 23% 24% 20%
0 0 1 2 3 1 2 2 4 4 5 12
EPS in Rs 0.02 0.01 0.03 0.12 0.14 0.04 0.12 0.10 0.21 0.21 0.26 0.52
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 4%
3 Years: 4%
TTM: 3%
Compounded Profit Growth
10 Years: 50%
5 Years: 40%
3 Years: 40%
TTM: 161%
Stock Price CAGR
10 Years: 25%
5 Years: 34%
3 Years: 11%
1 Year: 112%
Return on Equity
10 Years: 8%
5 Years: 9%
3 Years: 9%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 13 13 13 13 13 13 13 13 13 13 18 23
Reserves 13 13 13 16 18 19 21 23 27 31 61 148
2 3 4 2 4 2 5 5 7 10 1 1
9 11 10 11 14 16 13 16 12 14 16 34
Total Liabilities 36 40 39 42 49 50 52 57 59 68 96 205
16 16 15 15 16 16 16 15 14 14 15 16
CWIP 0 0 0 0 0 0 0 0 0 0 0 1
Investments 7 7 7 7 7 7 7 7 7 7 8 8
13 16 18 19 26 28 29 35 38 48 73 180
Total Assets 36 40 39 42 49 50 52 57 59 68 96 205

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-2 0 0 3 -0 3 2 -2 -1 7 -14 -33
-1 -1 -0 -1 -1 -1 -1 -0 -0 -1 -1 1
0 0 0 -2 1 -2 1 -0 2 2 21 79
Net Cash Flow -2 0 0 0 -0 0 2 -2 0 7 6 47

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 49 51 71 66 90 87 68 41 55 67 49 74
Inventory Days 34 29 23 47 43 31 57 78 50 72 133 153
Days Payable 103 117 121 114 139 161 88 86 59 72 58 136
Cash Conversion Cycle -20 -38 -27 -0 -7 -43 38 34 46 67 125 90
Working Capital Days 55 65 88 76 106 93 86 119 153 148 240 470
ROCE % 3% 4% 5% 12% 12% 6% 10% 8% 14% 12% 11% 13%

Shareholding Pattern

Numbers in percentages

5 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
22.05% 22.05% 22.05% 22.05% 23.38% 23.38% 23.38% 23.38% 23.61% 23.61% 18.41% 18.41%
77.95% 77.95% 77.95% 77.95% 76.63% 76.62% 76.62% 76.62% 76.39% 76.39% 81.58% 81.57%
No. of Shareholders 46,38050,05256,68957,87759,17258,24855,60952,98150,98869,72383,99687,820

Documents

Announcements

Annual reports

Right Issue